Concepedia

Su Lu

SL

Statistics

Publications

7

Citations

147

H-Index

7

Active since

2014

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Su Lu is an author at Tianjin Medical University Cancer Institute and Hospital specializing in molecular oncology, cancer cell signaling, and oncology.

ORCID

Publications per year

2014–2023

7

Publications

7

CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation

Liqiang Qi, Bo Sun, Beibei Yang et al. · Human Molecular Genetics · 2023 · 31 citations · Full text

, , +15

Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases

Yang Li, Su Lu, Yuhan Zhang et al. · World Journal of Surgical Oncology · 2021 · 30 citations · Full text

, , +17

CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p/ZEB2 axis

Liqiang Qi, Bo Sun, Beibei Yang et al. · Cancer Cell International · 2021 · 21 citations · Full text

, , +17

circRNA RPPH1 Facilitates the Aggravation of Breast Cancer Development by Regulating miR-542-3p/ARHGAP1 Pathway

Liqiang Qi, Bo Sun, Beibei Yang et al. · Cancer Biotherapy and Radiopharmaceuticals · 2021 · 19 citations

, , +17

Modulation of BAG-1 Expression Alters the Sensitivity of Breast Cancer Cells to Tamoxifen

Hong Liu, Su Lu, Lin Gu et al. · Cellular Physiology and Biochemistry · 2014 · 16 citations · Full text

, , +12

1–5 of 7